 Vertigo

1. GENERIC NAME:  Floating feeling

 Erythromycin (topical)  Confusion
BRAND NAME: NURSING
 Akne-Mycin RESPONSIBILITIES/PRECAUTIONS
CLASSIFICATION:  Monitor respiratory and cardiovascular
 Anti-infective function and urine output.
ROUTE:  Carefully monitor hematologic studies
 IV and hepatic enzyme levels.
DOSAGE/FREQUENCY:
  Tell patient to place sublingual
THERAPEUTIC tablets on floor of mouth directly
ACTIONS under tongue immediately after
 Binds with 50S subunit of susceptible removal from blister unit
bacterial ribosomes, suppressing  Advise patient not to breastfeed
protein synthesis in bacterial cells and while taking drug.
causing cell death
INDICATIONS
 Pelvic inflammatory disease 3.GENERIC NAME:
 Syphilis  Methylergonovine Maleate
 Intestinal amebiasis BRAND NAME:
CONTRAINDICATIONS  Methergine
 Hypersensitivity to drug or tartrazine CLASSIFICATION:
 Hepatic impairment  Oxytocic
 Pregnancy ROUTE:
SIDE EFFECTS  Oral
  IV
  IM
 DOSAGE/FREQUENCY:
NURSING 
RESPONSIBILITIES/PRECAUTIONS THERAPEUTIC
 Check temperature, and watch for ACTIONS
signs and symptoms of superinfection.  Directly stimulates vascular smoothmuscle
 Assess patient’s hearing for signs of contractions in uterus and
ototoxicity. cervix and decreases bleeding after
 If drug causes GI upset, encourage delivery
patient to take it with food. INDICATIONS
 Prevention and treatment of postpartum
hemorrhage
CONTRAINDICATIONS
2. GENERIC NAME:  Hypersensitivity to drug
 Fentanyl  Hypertension
BRAND NAME:  Toxemia
 Subsys  Pregnancy
CLASSIFICATION: SIDE EFFECTS
 Opioid analgesic  Dizziness
ROUTE:  Headache
 Oral  Hallucination
DOSAGE/FREQUENCY:
 Seizures

THERAPEUTIC NURSING
ACTIONS RESPONSIBILITIES/PRECAUTIONS
 Binds to specific opioid receptors in  When giving I.V., closely monitor
CNS, inhibiting pain pathways, altering blood pressure, pulse, uterine contractions,
pain perception, and increasing pain and bleeding.
threshold  Monitor patient for adverse effects.
INDICATIONS  Inform patient and family of reason
 Breakthrough pain in opioidtolerant for using drug, and provide reassurance.
patients with cancer  Tell patient drug may cause nausea,
CONTRAINDICATIONS vomiting, dizziness, increased blood
 Opioid-nontolerant patient pressure, headache, ringing in ears,
 Intermittent pain chest pain, or shortness of breath.
 Management of acute or mild pain
SIDE EFFECTS
 Headache
 Dizziness
4.GENERIC NAME:  Addiction
 Meperidine hydrochloride  Hemorrhage
BRAND NAME:  Bronchial asthma
 Demerol  Increased icp
CLASSIFICATION: SIDE EFFECTS
 Analgesic  Drowsiness
ROUTE:
 Oral/IM  Dizziness
DOSAGE/FREQUENCY:  Confusion
  Headache
THERAPEUTIC  Sedation
ACTIONS  Euphoria
 Binds to and depresses opiate receptors  Insomnia
in spinal cord and CNS, altering perception NURSING
of and response to pain RESPONSIBILITIES/PRECAUTIONS
INDICATIONS  Access pain location type character intensity
 Moderate to severe pain give dose before paying become extreme
 Preoperative sedation  Monitor vital signs.
 Support of anesthesia  Monitor fluid intake and output.
 Analgesia during labor
CONTRAINDICATIONS
 Hypersensitivity to drug or bisulfites 6.GENERIC NAME:
 MAO inhibitor use within past  Nalbuphine Hydrochloride
14 days BRAND NAME:
SIDE EFFECTS  Nubain
 Confusion CLASSIFICATION:
 Sedation  Analgesic
 Dysphoria, ROUTE:
 Euphoria  IV
 Floating feeling  IM
NURSING DOSAGE/FREQUENCY:
RESPONSIBILITIES/PRECAUTIONS 
THERAPEUTIC
 Monitor vital signs.
ACTIONS
 Reassess patient’s pain level after  Binds to opiate receptors in CNS,
administration. inhibiting ascending pain pathways.
 Evaluate bowel and bladder function. This inhibition alters perception of
 Tell patient using oral solution or and response to painful stimuli.
syrup to take drug with a half-glass of INDICATIONS
water to minimize local anesthetic  Moderate to severe pain
effect.  Adjunct to balanced anesthesia
 Advise patient to avoid alcohol. CONTRAINDICATIONS
 Hypersensitivity to drug
SIDE EFFECTS
 Dizziness
5.GENERIC NAME:
 Sedation
 Morphine
BRAND NAME:  Headache
 Astramorph PF  Vertigo
CLASSIFICATION: NURSING
RESPONSIBILITIES/PRECAUTIONS
 Opioid analgesic
ROUTE:  Monitor vital signs.Watch for respiratory
 IV depression and heart rate changes.
 IM  Evaluate patient for CNS changes.
DOSAGE/FREQUENCY: Institute safety measures as needed to
 10 to 30 mg P.R. q 4 hours p.r.n. prevent injury.
THERAPEUTIC  Tell patient to avoid CNS depressants
ACTIONS  Advise patient to consult prescriber
 Depresses pain impulse transmission at the before taking herbs.
spinal cord level by interacting with opioid
receptors
 Decreased pain
INDICATIONS 7.GENERIC NAME:
 Moderate to severe pain  Oxytocin
BRAND NAME:
CONTRAINDICATIONS  Pitocin
 Hyper sensitivity CLASSIFICATION:
 Uterine-active agent
ROUTE:
 IV
DOSAGE/FREQUENCY:

THERAPEUTIC
ACTIONS
 Thought to directly stimulate
smooth muscle contractions in
uterus and cervix.
INDICATIONS
 To induce or stimulate labor
 To control postpartum bleeding
 Incomplete abortion
CONTRAINDICATIONS
 Hypersensitivity to drug
 Fetal distress when delivery is not
imminent
 Prolonged use in uterine inertia or
severe toxemia
SIDE EFFECTS
 Seizures
 Coma
 Neonatal brain damage
NURSING
RESPONSIBILITIES/PRECAUTIONS
 Monitor patient extremely closely
during first and second stages of labor
because of risk of cervical laceration
 Assess fluid intake and output
 Monitor and record vaginal bleeding.
 Inform patient about risks and benefits
of oxytocin-induced labor.